Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Integral Diagnostics Ltd. ( (AU:IDX) ) is now available.
Integral Diagnostics Ltd. has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, ensuring transparency and accountability in its operations. This announcement underscores Integral Diagnostics’ commitment to maintaining robust governance practices, which is crucial for its reputation and trust among stakeholders.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.30 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates in the healthcare industry, providing diagnostic imaging services. The company focuses on delivering high-quality medical imaging services across Australia and New Zealand, catering to the needs of healthcare professionals and patients.
Average Trading Volume: 1,043,981
Technical Sentiment Signal: Buy
Current Market Cap: A$998.1M
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.